nafamostat has been researched along with ammonium hydroxide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azuma, T; Eguchi, S; Fujioka, H; Furui, J; Kamohara, Y; Kanematsu, T; Kawashita, Y; Kawazoe, Y; Sugiyama, N | 1 |
| Fukuda, J; Funatsu, K; Ijima, H; Nakazawa, K; Rikimaru, T; Sakiyama, R; Shimada, M; Sugimachi, K; Tsujita, E; Yamashita, Y | 1 |
2 other study(ies) available for nafamostat and ammonium hydroxide
| Article | Year |
|---|---|
Efficacy of Nafamostat Mesilate for improving the performance of a bioartificial liver using porcine hepatocytes.
Topics: Alanine Transaminase; Ammonia; Animals; Benzamidines; Cell Survival; Complement Inactivator Proteins; Female; Guanidines; Humans; In Vitro Techniques; Liver; Liver Failure; Liver, Artificial; Protease Inhibitors; Swine; Thrombin Time | 1999 |
The efficacy of nafamostat mesilate on the performance of a hybrid-artificial liver using a polyurethane foam/porcine hepatocyte spheroid culture system in human plasma.
Topics: Alanine Transaminase; Ammonia; Animals; Benzamidines; Cell Survival; Female; Guanidines; Humans; Liver; Liver Failure; Liver, Artificial; Plasma; Polyurethanes; Protease Inhibitors; Swine; Transaminases | 2001 |